Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors
LCx using combined DNA and RNA NGS testing of CSF is a reliable approach that yields potentially practice-changing clinical information, and suggests that LBx using combined DNA and RNA NGS testing of CSF is a reliable approach that yields potentially practice-changing clinical information.